Latest News

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

Florida ADAP cuts eligibility from 400% to 130% FPL, threatening 16,000 PLWHA.

State Prescription Drug Affordability Boards limit public input while basing pricing decisions on flawed methodologies.

PDAB state implementation variations and how patients can engage in the process.

Iowa's elimination of HIV/AIDS education threatens youth prevention and LGBTQ health outcomes.

CANN and ADAP issue Florida travel advisory due to discriminatory LGBTQ legislation.

Tennessee rejects $8.3M in federal HIV prevention funding, threatening surveillance and care programs.

State-level MPV surveillance: Black Americans overrepresented in Southern states amid reporting gaps.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

Stigma drives opposition to harm reduction programs like safe consumption sites despite strong evidence.

Medicaid sobriety restrictions on HCV treatment contradict harm reduction and elimination goals.

Arizona's restrictive Medicaid formulary limits single-tablet HIV regimens and HCV agents post-expansion.